公开(公告)号：US20180153947A1

公开(公告)日：2018-06-07

申请号：US15317603

申请日：2015-06-11

Applicant: BIOCODEX

Inventor： Jean-Marie LEFEVRE ,  Gilles RENAUD ,  Marie-Emmanuelle LE GUERN

IPC: A61K36/064 ,  A61J1/20 ,  A61J7/00 ,  A61K9/19 ,  A61K47/26 ,  A61K47/12 ,  A61P1/12 ,  A23L33/14 ,  A23L33/16 ,  A23L33/155 ,  A23L33/125

CPC classification number: A61K36/064 ,  A23L33/125 ,  A23L33/14 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23P10/40 ,  A23V2002/00 ,  A61J1/2093 ,  A61J7/0046 ,  A61K9/19 ,  A61K47/12 ,  A61K47/26 ,  A61P1/12

Abstract: The present invention relates to a dietary supplement or pharmaceutical composition, comprising lyophylized Saccharomyces boulardii as an active ingredient and as sole probiotic, optionally in association with a pharmaceutically acceptable vehicle, wherein the composition is in a closed vial a having a first airtight compartment comprising lyophilized S. boulardii powder, and a second compartment comprising a solution, wherein the first and second compartment can be brought in airtight communication with one another to yield a suspension of S. boulardii to be administered to an individual upon opening of the vial.